Recent Updates
Recently added Catalysts
AMS

AMERICAN SHARED HOSPITAL SERVICES FOURTH QUARTER REVENUE INCREASED 19% OPERATING INCOME INCREASED TO A NEW RECORD San Francisco, CA

Key Takeaway: AMERICAN SHARED HOSPITAL SERVICES FOURTH QUARTER REVENUE INCREASED 19% OPERATING INCOME INCREASED TO A NEW RECORD San Francisco, CA, February 22, 2006 AMERICAN SHARED HOSPITAL SERVICES (AMEX,PCX:AMS), the leading provider of Gamma Knife radiosurgery services, today announced

Full Press Release Details

AMERICAN SHARED HOSPITAL SERVICES
FOURTH QUARTER REVENUE INCREASED 19%
OPERATING INCOME INCREASED TO A NEW RECORD
San Francisco, CA, February 22, 2006 AMERICAN SHARED HOSPITAL SERVICES (AMEX,PCX:AMS), the
leading provider of Gamma Knife radiosurgery services, today announced financial results for the
fourth quarter and 2005, highlighted by a 19% increase in fourth quarter revenue and record
Fourth Quarter Results
For the three months ended December 31, 2005, revenue increased 19% to $4,650,000 compared to
$3,910,000 for the same period last year. Operating income increased for the 20th consecutive
quarter to a record $914,000, and pre-tax income increased 9% compared to the prior-year period.
Net income for fourth quarter 2005 increased to $479,000, or $0.09 per diluted share. This
compares to net income for fourth quarter 2004 of $386,000, or $0.08 per diluted share. The
effective tax rate for the fourth quarter 2005 was 30% compared to 38% for the same period in 2004,
primarily reflecting adjustments to the estimated state income tax effective rates.
At December 31, 2005, AMS reported working capital of $2,423,000, cash, cash equivalents and
short-term securities of $5,835,000, and long-term securities of $2,797,000. At December 31, 2004,
cash, cash equivalents and short-term securities were $9,078,000 and the Company held no long-term
securities. Shareholders equity increased to $18,320,000 compared to $17,546,000 at December 31,
For the twelve months ended December 31, 2005, revenue increased 11% to $18,231,000 from
$16,389,000 for 2004. Operating income increased 6% to a record $3,471,000 from $3,278,000 for the
prior year. Income before income taxes increased 6%, to $2,547,000 from $2,397,000 a year earlier.
Net income for 2005 decreased to $1,767,000, or $0.35 per diluted share, from $1,985,000, or $0.39
per diluted share, for 2004, reflecting primarily a reduction in income tax benefit for 2005
Growth in 2005 was driven by the addition of three new Gamma Knife units to our portfolio during
the year, as well as higher same-center treatment volume. Profitability also benefited from our
focus on effective cost management at the corporate level and at our 21 Gamma Knife units now in
operation, said Ernest A. Bates, M.D., Chairman and Chief Executive Officer.
As a leader in the market for Gamma Knife units and other advanced therapeutic equipment, AMS has
an outstanding long-term growth opportunity. While we were disappointed that we did not enter into
any new contracts in 2005, we continue to work through the sales process with several potential new
clients and we are confident that contracts will be awarded to AMS soon. We continue to explore
opportunities for Gamma Knife units, the latest Intensity Modulated Radiation Therapy (IMRT) and
Image Guided Radiation Therapy (IGRT) equipment and our proprietary Operating Room for the 21st
Century concept. We are optimistic about the outlook for 2006, Dr. Bates added.
Earnings Conference Call
American Shared has scheduled a conference call at 4:00 pm EDT (1:00 pm PDT) today. To participate
in the live call, dial 800-471-6718 at least 5 minutes prior to the scheduled start time. A
simultaneous WebCast of the call may be accessed through the Company s website,
www.ashs.com, or through CCBN, www.earnings.com. A replay will be available for 30
days at these same internet addresses, or by calling 888-843-8996, pass code 13832223.
American Shared Hospital Services is building a profitable medical services company in an
underserved niche turnkey technology solutions for advanced radiosurgical procedures. The
Company s core business is supplying hospitals with the Gamma Knife a non-invasive treatment for
malignant and benign brain tumors, vascular malformations and trigeminal neuralgia (facial pain).
The Gamma Knife, the gold standard in radiosurgery, reduces surgical risk and patient discomfort,
resulting in a shorter hospital stay and lower risk of complications. In most cases, Gamma Knife
patients resume their normal activities within a few days of treatment, compared to weeks or months
for patients who undergo conventional surgery. More than 250,000 patients worldwide have already
received this treatment. American Shared Hospital Services is the world leader in providing Gamma
Knife radiosurgery services.
Safe Harbor Statement
This press release may be deemed to contain certain forward-looking statements with respect to the
financial condition, results of operations and future plans of American Shared Hospital Services,
which involve risks and uncertainties including, but not limited to, the risks of the Gamma Knife
business and the risks of developing its IMRT and The Operating Room for the 21st
Century programs. Further information on potential factors that could affect the financial
condition, results of operations and future plans of American Shared Hospital Services is included
in the filings of the Company with the Securities and Exchange Commission, including the Company s
Annual Report on Form 10-K for the year ended December 31, 2004, its Quarterly Report on Form 10-Q
for the periods ended March 31, 2005, June 30, 2005 and September 30, 2005 and the definitive Proxy
Statement for the Annual Meeting of Shareholders held on June 16, 2005.
Contacts: American Shared Hospital Services
Ernest A. Bates, M.D., (415) 788-5300
Chairman and Chief Executive Officer
e.bates@ashs.com
Berkman Associates
Neil Berkman, Ph.D., (310) 826-5051
President
info@berkmanassociates.com
AMERICAN SHARED HOSPITAL SERVICES
Summary of Operations Data
Three months ended December 31, Twelve months ended December 31,
2005 2004 2005 2004
Revenue $ 4,650,000 $ 3,910,000 $ 18,231,000 $ 16,389,000
Costs of revenue 2,273,000 1,951,000 9,072,000 7,887,000
Gross margin 2,377,000 1,959,000 9,159,000 8,502,000
Selling administrative expense 965,000 618,000 3,613,000 2,963,000
Interest expense 498,000 534,000 2,075,000 2,261,000
Operating income 914,000 807,000 3,471,000 3,278,000
Interest other income 73,000 38,000 202,000 102,000
Minority interest expense (302,000 ) (219,000 ) (1,126,000 ) (983,000 )
Income before income taxes 685,000 626,000 2,547,000 2,397,000
Income tax expense 206,000 240,000 780,000 412,000
Net income $ 479,000 $ 386,000 $ 1,767,000 $ 1,985,000
Earnings per common share:
Basic $ 0.10 $ 0.08 $ 0.36 $ 0.46
Assuming dilution $ 0.09 $ 0.08 $ 0.35 $ 0.39
Balance Sheet Data
12/31/2005 12/31/2004
Cash and cash equivalents $ 1,298,000 $ 8,121,000
Securities-current maturities $ 4,537,000 $ 957,000
Current assets $ 10,709,000 $ 12,672,000
Securities-long term $ 2,797,000 $ 0
Total assets $ 48,668,000 $ 47,106,000
Current liabilities $ 8,286,000 $ 7,955,000
Shareholders equity $ 18,320,000 $ 17,546,000
Last updated: Feb 22, 2006